48 results on '"Stuart, O. Anthony"'
Search Results
2. HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study
3. Unusually favorable outcome of 6 consecutive patients with diffuse malignant peritoneal mesothelioma treated with repeated doses of intraperitoneal paclitaxel. A case series
4. Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration
5. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C
6. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
7. Intraperitoneal gemcitabine chemotherapy is safe for patients with resected pancreatic cancer: final clinical and pharmacologic data from a phase II protocol and recommended future directions
8. Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan
9. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor
10. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
11. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions
12. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics
13. Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia
14. Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C
15. Intraperitoneal doxorubicin achieves access to mesenteric lymph nodes, case series of two patients
16. Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients
17. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model
18. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C
19. Letters to the Editor
20. Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer: Rationale and Report of Early Data
21. Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
22. Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication
23. Hyperthermic Intraoperative Thoracoabdominal Chemotherapy
24. Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival
25. Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
26. Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
27. Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
28. Pharmacology of perioperative 5‐Fluorouracil
29. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis
30. Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy
31. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C
32. Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy
33. Docetaxel and hyperthermia: Factors that modify thermal enhancement
34. Pharmacokinetics of intraperitoneal oxaliplatin: Experimental studies
35. Pharmacokinetics of Intraperitoneal Gemcitabine in a Rat Model
36. Heated Intraoperative Intraperitoneal Mitomycin C and Early Postoperative Intraperitoneal 5-Fluorouracil: Pharmacokinetic Studies
37. CLINICAL EXPERIENCE WITH A NEW TECHNIQUE OF HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY
38. RISK FACTORS OF MORBIDITY AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE SURGERY AND HEATED INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS
39. MULTIPLE SURGICAL OPTIONS IN THE PREVENTION AND TREATMENT OF CANCER SEEDING INTO THE ABDOMEN AND PELVIS
40. Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration
41. Effect of intraperitoneal chemotherapy and fibrinolytic therapy on tumor implantation in wound sites
42. Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions
43. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
44. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.
45. Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy.
46. Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer.
47. Prevention of intraperitoneal adhesions by intraperitoneal lavage and intraperitoneal 5-fluorouracil: experimental studies.
48. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.